France· FR:63227488
CELLCEPT 500 mg, poudre pour solution à diluer pour perfusion
A medicinal product containing chlorhydrate de mycophénolate mofétil, registered in France by ROCHE REGISTRATION (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE MYCOPHÉNOLATE MOFÉTIL
- Manufacturer
- ROCHE REGISTRATION (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009561939434 flacon(s) en verre de 20 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de mycophénolate mofétil in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCellcept 500 mg poeder voor concentraat voor oplossing voor infusieRoche Registration GmbH
- SwitzerlandCellcept
- PolandCellCeptRoche Registration GmbH
- IcelandCellceptRoche Registration GmbH*
- CanadaAPO-MYCOPHENOLIC ACIDAPOTEX INC
- SwedenMyfortic 180 mg EnterotablettNovartis Sverige AB
- United KingdomCeptava 180mg gastro-resistant tabletsSandoz Ltd
- ItalyACIDO MICOFENOLICO ACCORDACCORD HEALTHCARE B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Mycophenolsäure Accord, Myfortic
- Belgium · Myfortic
- Bulgaria · Mифортик
- Cyprus · Myfortic
- Czechia · Mycophenolic Acid Accord, Myfortic
- Germany · Mycophenolat Mofetil Accord, Mycophenolatmofetil Heumann
- Denmark · Myastad, Mycophenolsyre Accord
- Estonia · Myfortic
- Spain · Ácido Micofenólico Stada, Myfortic
- Finland · Myastad, Myfortic
- United Kingdom (Northern Ireland) · Mycophenolic Acid Accord Healthcare, Myfortic
- Greece · Myfortic
- Croatia · Mikofenolatna Kiselina Accord, Myfortic
- Hungary · Mikofenolsav Tillomed, Myfortic
- Ireland · Myfortic
- Iceland · Mycofenolsýra Accord, Myfortic
- Italy · Acido Micofenolico Accord, Acido Micofenolico Tillomed
- Lithuania · Myfortic
- Luxembourg · Myfortic
- Latvia · Myfortic
- Malta · Myfortic
- Netherlands · Mycofenolzuur Accord, Myfortic
- Norway · Myfortic, Mykofenolsyre Accord
- Poland · Marelim, Myfortic
- Portugal · Ácido Micofenólico Accord, Ácido Micofenólico Tillomed
- Romania · Myfortic
- Sweden · Myfortic, Mykofenolsyra Accord
- Slovenia · Myfortic
- Slovakia · Myfortic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/565086da-9607-48d2-af15-3a77869f81e8 GET /v1/drugs/565086da-9607-48d2-af15-3a77869f81e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63227488",
"date_amm": "1998-10-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/96/005",
"substance": "CHLORHYDRATE DE MYCOPHÉNOLATE MOFÉTIL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de mycophénolate mofétil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.